JP2021091740A - 美容組成物 - Google Patents
美容組成物 Download PDFInfo
- Publication number
- JP2021091740A JP2021091740A JP2021044136A JP2021044136A JP2021091740A JP 2021091740 A JP2021091740 A JP 2021091740A JP 2021044136 A JP2021044136 A JP 2021044136A JP 2021044136 A JP2021044136 A JP 2021044136A JP 2021091740 A JP2021091740 A JP 2021091740A
- Authority
- JP
- Japan
- Prior art keywords
- present
- skin
- ceramides
- composition
- beauty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 239000002537 cosmetic Substances 0.000 title abstract description 8
- 229940106189 ceramide Drugs 0.000 claims abstract description 39
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims abstract description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004472 Lysine Substances 0.000 claims abstract description 5
- 150000001783 ceramides Chemical class 0.000 claims description 37
- 230000003796 beauty Effects 0.000 claims description 32
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 abstract description 23
- 210000005175 epidermal keratinocyte Anatomy 0.000 abstract description 20
- 230000004888 barrier function Effects 0.000 abstract description 10
- 230000003213 activating effect Effects 0.000 abstract description 7
- 230000007306 turnover Effects 0.000 abstract description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 25
- 239000004480 active ingredient Substances 0.000 description 23
- 108010035532 Collagen Proteins 0.000 description 18
- 102000008186 Collagen Human genes 0.000 description 18
- 229920001436 collagen Polymers 0.000 description 16
- 235000013305 food Nutrition 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 230000008591 skin barrier function Effects 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 235000003599 food sweetener Nutrition 0.000 description 12
- 239000003765 sweetening agent Substances 0.000 description 12
- 102000016611 Proteoglycans Human genes 0.000 description 11
- 108010067787 Proteoglycans Proteins 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 230000020411 cell activation Effects 0.000 description 9
- 239000008187 granular material Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000209094 Oryza Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 150000002305 glucosylceramides Chemical class 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- 108010011485 Aspartame Proteins 0.000 description 7
- 239000000605 aspartame Substances 0.000 description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 7
- 229960003438 aspartame Drugs 0.000 description 7
- 235000010357 aspartame Nutrition 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 230000008417 skin turnover Effects 0.000 description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910052750 molybdenum Inorganic materials 0.000 description 5
- 239000011733 molybdenum Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 3
- 235000013539 calcium stearate Nutrition 0.000 description 3
- 239000008116 calcium stearate Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- -1 fatty acid menthol ester Chemical class 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229960003646 lysine Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229960005337 lysine hydrochloride Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WRFPVMFCRNYQNR-UHFFFAOYSA-N 2-hydroxyphenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1O WRFPVMFCRNYQNR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- PDKHNCYLMVRIFV-UHFFFAOYSA-H molybdenum;hexachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mo] PDKHNCYLMVRIFV-UHFFFAOYSA-H 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Abstract
Description
(a)アスパルテーム、還元パラチノース、及び還元麦芽糖から選ばれる少なくとも1種の甘味料
(b)システイン、ロイシン、リシン、メチオニン、及びチロシンから選ばれる少なくとも1種のアミノ酸
(c)鉄、及びモリブデンから選ばれる少なくとも1種のミネラル類
(d)コラーゲン、及びプロテオグリカンから選ばれる少なくとも1種の美容成分
本発明に用いられるセラミド類としては、セラミド1、セラミド2、セラミド3等のヒト型セラミドの他、牛、馬、豚等の脳、脊髄等から抽出した動物由来のセラミド、小麦、米、大豆、ホウレンソウ等から抽出した植物由来のセラミドを用いることができる。また、本発明に用いられるセラミド類としては、糖セラミドであってもよく、具体的に例えば、ガラクトシルセラミド、グルコシルセラミド等の単糖が結合したものや、オリゴ糖が結合したものを挙げることができる。
(a)甘味料
本発明の美容組成物においては、セラミド類と共に、有効成分として、アスパルテーム、還元パラチノース、及び還元麦芽糖から選ばれる少なくとも1種の甘味料を用いることが好ましい。本発明の甘味料とは、甘味を呈するものを意味し、甘味料としての使用目的に限定されない。
本発明の美容組成物においては、セラミド類と共に、有効成分として、システイン、ロイシン、リシン、メチオニン、及びチロシンから選ばれる少なくとも1種のアミノ酸(塩を含む)を用いることが好ましい。塩としては、例えば、ナトリウム塩、塩酸塩等を挙げることができる。
本発明の美容組成物においては、セラミド類と共に、有効成分として、鉄、及びモリブデンから選ばれる少なくとも1種のミネラル類を用いることが好ましい。なお、本発明のミネラル類としての鉄、モリブデンは、それぞれ鉄、モリブデンを含む化合物の形態を含む。
本発明の美容組成物においては、セラミド類と共に、有効成分として、コラーゲン、及びプロテオグリカンから選ばれる少なくとも1種の美容成分を用いることが好ましい。
[実施例1]
1.細胞培養
(1)37℃、5%CO2インキュベーター内で、75cm2フラスコを用いて、正常ヒト表皮角化細胞(NHEK)を専用培地により培養した。
(2)トリプシン処理により浮遊させた細胞を、75cm2フラスコから96well plateの各wellに1.0×104cells/wellの細胞密度で播種した。
(3)37℃、5%CO2インキュベーター内で24時間前培養した。
(4)各wellより培地を除去後、所定濃度に調製した被験物質含有培地を200μLずつ添加し、CO2インキュベーター内で48時間培養した。
(1)48時間培養後、培養した細胞から培地を除去し、PBS 200μL/wellで1回洗浄後、無血清DMEMで30倍に希釈したCell Counting Kit−8溶液を150μL添加した。
(2)37℃、5%CO2インキュベーター内に静置し適度に発色させた後、450nmにおける吸光度を測定した。
(3)得られたデータを元にcontrolに対する細胞賦活活性率(% of control)を算出した。
下記成分を混合して打錠し、タブレット(300mg)を製造した。本タブレットを1日に2錠を水などと共に飲み下すことで摂取する。
還元パラチノース 40.0
コラーゲンペプチド 25.0
米由来グルコシルセラミド 3.3
ブタプラセンタ 14.0
セルロース 10.0
ナイアシン 2.0
ステアリン酸カルシウム 3.2
二酸化ケイ素 2.0
ビタミンB2 0.3
ビタミンB6 0.2
下記成分の混合物をソフトカプセルに封入し、カプセル剤(600mg)を製造した。本カプセル剤は一日に1カプセルを摂取する。
還元麦芽糖 20.0
米由来グルコシルセラミド 4.0
コラーゲンペプチド 25.0
プロテオグリカン 25.0
ビタミンC 10.0
システイン 5.0
メチオニン 5.0
塩化鉄 6.0
下記成分を混合して常法により顆粒剤(1200mg)を製造した。
アスパルテーム 5.0
米由来グルコシルセラミド 0.2
セルロース 20.0
ステアリン酸カルシウム 20.0
コラーゲンペプチド 15.0
プロテオグリカン 15.0
ビタミンC 10.0
チロシン 2.8
ロイシン 2.0
下記成分を混合して常法によりインスタント粉末(5000mg)を製造した。
アスパルテーム 5.0
米由来グルコシルセラミド 0.05
セルロース 20.0
ステアリン酸カルシウム 20.0
コラーゲンペプチド 15.0
プロテオグリカン 15.0
ビタミンC 10.0
ビタミンB1 4.0
ビタミンB2 3.0
ビタミンE 3.0
チロシン 2.8
ロイシン 2.0
下記成分からなる液剤(50mL)を製造した。
還元麦芽糖 5.0
アスパルテーム 1.0
米由来グルコシルセラミド 0.01
コラーゲンペプチド 7.0
プロテオグリカン 5.0
ビタミンC 2.0
ビタミンB1 0.5
ビタミンB2 0.5
ビタミンE 0.2
チロシン 0.1
ロイシン 0.1
リシン−塩酸塩 1.0
水 残部
Claims (2)
- セラミド類と、リシン、チロシン、及び還元パラチノースからなる群より選ばれる少なくとも1種の成分とを含有することを特徴とする美容組成物。
- 肌の保湿力を高めるために用いる肌保湿用組成物であることを特徴とする請求項1記載の美容組成物。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021044136A JP7270996B2 (ja) | 2021-03-17 | 2021-03-17 | 美容組成物 |
JP2023067552A JP2023083420A (ja) | 2021-03-17 | 2023-04-18 | 美容組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021044136A JP7270996B2 (ja) | 2021-03-17 | 2021-03-17 | 美容組成物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019104548A Division JP6858986B2 (ja) | 2019-06-04 | 2019-06-04 | 美容組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023067552A Division JP2023083420A (ja) | 2021-03-17 | 2023-04-18 | 美容組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021091740A true JP2021091740A (ja) | 2021-06-17 |
JP7270996B2 JP7270996B2 (ja) | 2023-05-11 |
Family
ID=76311723
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021044136A Active JP7270996B2 (ja) | 2021-03-17 | 2021-03-17 | 美容組成物 |
JP2023067552A Pending JP2023083420A (ja) | 2021-03-17 | 2023-04-18 | 美容組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023067552A Pending JP2023083420A (ja) | 2021-03-17 | 2023-04-18 | 美容組成物 |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP7270996B2 (ja) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002272418A (ja) * | 2001-03-19 | 2002-09-24 | Vivo Corporation Co Ltd | 健康食品とその製法 |
JP2012006870A (ja) * | 2010-06-25 | 2012-01-12 | Shiseido Co Ltd | 皮膚外用剤 |
-
2021
- 2021-03-17 JP JP2021044136A patent/JP7270996B2/ja active Active
-
2023
- 2023-04-18 JP JP2023067552A patent/JP2023083420A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002272418A (ja) * | 2001-03-19 | 2002-09-24 | Vivo Corporation Co Ltd | 健康食品とその製法 |
JP2012006870A (ja) * | 2010-06-25 | 2012-01-12 | Shiseido Co Ltd | 皮膚外用剤 |
Non-Patent Citations (5)
Title |
---|
"Cream", MINTEL GNPD, vol. (ID#)2303381, JPN6022040787, 2014, ISSN: 0004885812 * |
"Crystal Gel Gold", MINTEL GNPD, vol. (ID#)2967725, JPN6022011846, February 2015 (2015-02-01), ISSN: 0004885815 * |
"Repair Moist Lotion", MINTEL GNPD, vol. (ID#)2790463, JPN6022011847, 2014, ISSN: 0004885816 * |
COSMETIC STAGE, vol. 9, no. 6, JPN6022040785, 2015, pages 18 - 26, ISSN: 0004885813 * |
ファインケミカル, vol. 42, no. 3, JPN6022040786, 2013, pages 60 - 61, ISSN: 0004885814 * |
Also Published As
Publication number | Publication date |
---|---|
JP2023083420A (ja) | 2023-06-15 |
JP7270996B2 (ja) | 2023-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5894341B2 (ja) | コラーゲンペプチド、エラスチンペプチドおよびプロテオグリカンを含む組成物 | |
JP6858986B2 (ja) | 美容組成物 | |
JP2016193857A (ja) | 皮膚化粧料および飲食品 | |
WO2015015816A1 (ja) | 繊維芽細胞賦活剤 | |
EP3290041B1 (en) | Oral care composition | |
JP2007197371A (ja) | 美肌促進剤及び美容健康食品 | |
JP5712393B2 (ja) | コラーゲン類吸収促進剤及びその利用 | |
JP7270996B2 (ja) | 美容組成物 | |
JP7071754B2 (ja) | 関節機能改善組成物 | |
JP6718158B2 (ja) | 肝機能改善剤 | |
JP6742575B2 (ja) | 関節機能改善組成物 | |
US20100197611A1 (en) | Alternative agent with vitamin d-like activity and an improving agent for intestinal function | |
JP2017007966A (ja) | 美容組成物 | |
JP6841444B2 (ja) | 免疫賦活剤 | |
TWI576117B (zh) | 玻尿酸產生促進劑 | |
JP2020186264A (ja) | 血中中性脂肪上昇抑制組成物 | |
JP2020094015A (ja) | ヒアルロン酸産生促進剤、関節機能改善剤、及び経口用組成物 | |
JP7098198B2 (ja) | 美容組成物 | |
JPWO2015015815A1 (ja) | 繊維芽細胞賦活剤 | |
JP7070928B2 (ja) | 美容組成物 | |
JP6906248B2 (ja) | 美容組成物 | |
JP6744673B2 (ja) | 関節機能改善組成物 | |
JP6838752B2 (ja) | 血流改善組成物 | |
JP6612064B2 (ja) | 美容組成物 | |
JP2021066739A (ja) | 血流改善組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210318 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220517 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221003 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20221130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221226 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230410 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230419 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7270996 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |